| Andrew Denicola, | |
|
111 Howard Ave, Cranston, RI 02920-3001 | |
| (401) 462-0325 | |
| Not Available |
| Full Name | Andrew Denicola |
|---|---|
| Gender | Male |
| Speciality | Counselor - Mental Health |
| Location | 111 Howard Ave, Cranston, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104318138 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | (* (Not Available)) | Secondary |
| 101YM0800X | Counselor - Mental Health | MHC01160 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Andrew Denicola, 111 Howard Ave, Cranston, RI 02920-3001 Ph: () - | Andrew Denicola, 111 Howard Ave, Cranston, RI 02920-3001 Ph: (401) 462-0325 |
News Archive
Given their palatability, tolerability and availability, dried plums should be considered the initial approach to the management of mild to moderate constipation in the general population, according to results of a randomized clinical trial recently published in Alimentary Pharmacology and Therapeutics.
Pulmatrix, Inc., previously known as Ruthigen, Inc., today announced the completion of its previously announced merger, effective June 15, 2015, and the closing of a private placement generating aggregate gross proceeds of $10.0 million. Participants in the private placement included pre-merger investors in Pulmatrix such as funds affiliated with 5AM Ventures, ARCH Venture Partners and Polaris Partners, as well as funds affiliated with Altitude Life Science Ventures.
Medivir AB (STO:MVIR-B) (OMX: MVIR), announces the initiation of a phase IIa trial in chronic genotype 1 hepatitis C infected patients to evaluate the efficacy, safety and tolerability of a 12-week combination therapy of simeprevir, TMC647055 and JNJ56914845, a NS5A replication complex inhibitor.
A trio of groundbreaking publications from researchers in Northwestern University's Physical Sciences-Oncology Center (PS-OC) report important methodological advances that will enable a better understanding of how gene expression is regulated, both in normal cells and in cancer cells. This knowledge could lead to the development of more effective therapeutic agents to treat cancer patients.
› Verified 5 days ago
Arturo Ramirez, Counselor Medicare: Not Enrolled in Medicare Practice Location: 9 Carlo Ct, Cranston, RI 02921 Phone: 781-697-9225 | |
Kathy Young, Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-724-8400 Fax: 401-722-5280 | |
Jaimie Gutierrez, LMHC-A Counselor Medicare: Not Enrolled in Medicare Practice Location: 1052 Park Ave, Cranston, RI 02910 Phone: 401-461-5056 | |
Elisabeth Merrell, Counselor Medicare: Not Enrolled in Medicare Practice Location: 15 Fleming Rd, Cranston, RI 02920 Phone: 800-455-8839 Fax: 866-455-8839 | |
Jeremy May, MASTERS, LMFT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-808-8685 | |
Dina Silva, LMHC Counselor Medicare: Not Enrolled in Medicare Practice Location: 156 Mulberry St, Cranston, RI 02910 Phone: 401-428-8065 | |
Kathryn Tarpey, BACHELORS Counselor Medicare: Not Enrolled in Medicare Practice Location: 1471 Elmwood Ave, Cranston, RI 02910 Phone: 401-490-7320 Fax: 401-490-7694 |